SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.84+2.8%Nov 18 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (22371)6/17/1998 10:01:00 AM
From: Henry Niman  Read Replies (2) of 32384
 
Rick, I did dig out an earlier post which gives some detail about the 11/26/96 RS report:
Message 3354673
For next year they projected a loss of $0.68. As I mentioned last night, all current projections (by Bear Stearns, H&Q, and Legg Mason) predict a profit for 1999 ($0.09, $0.11, $0.10) and BARS has a rough estimate of break even. The RS report did not predict a profit until 2000 ($0.10). Thus, it would appear that the 10 year report was rather conservative on its estimates of income (Targretin sales were projected to begin in 1999 and were estimated to be $22 million) and I suspect that most investors would be happy with an EPS of $14.55 in 2006.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext